- Home
- SNY vs NCMI Comparison
SNY vs NCMI Comparison
Compare SNY & NCMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- NCMI
- Stock Information
- Founded
- SNY 1994
- NCMI 2005
- Country
- SNY France
- NCMI United States
- Employees
- SNY N/A
- NCMI N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- NCMI Advertising
- Sector
- SNY Health Care
- NCMI Consumer Discretionary
- Exchange
- SNY Nasdaq
- NCMI Nasdaq
- Market Cap
- SNY 116.5B
- NCMI 476.2M
- IPO Year
- SNY N/A
- NCMI 2007
- Fundamental
- Price
- SNY $48.70
- NCMI $4.79
- Analyst Decision
- SNY Buy
- NCMI Strong Buy
- Analyst Count
- SNY 2
- NCMI 5
- Target Price
- SNY $62.50
- NCMI $7.40
- AVG Volume (30 Days)
- SNY 2.1M
- NCMI 603.6K
- Earning Date
- SNY 07-24-2025
- NCMI 08-04-2025
- Dividend Yield
- SNY 3.31%
- NCMI 2.51%
- EPS Growth
- SNY 39.56
- NCMI N/A
- EPS
- SNY 5.45
- NCMI N/A
- Revenue
- SNY $48,817,552,946.00
- NCMI $238,300,000.00
- Revenue This Year
- SNY $3.39
- NCMI $10.10
- Revenue Next Year
- SNY $7.05
- NCMI $11.66
- P/E Ratio
- SNY $17.56
- NCMI N/A
- Revenue Growth
- SNY N/A
- NCMI 42.10
- 52 Week Low
- SNY $45.80
- NCMI $4.12
- 52 Week High
- SNY $60.12
- NCMI $7.60
- Technical
- Relative Strength Index (RSI)
- SNY 43.32
- NCMI 38.30
- Support Level
- SNY $47.64
- NCMI $4.65
- Resistance Level
- SNY $49.37
- NCMI $4.99
- Average True Range (ATR)
- SNY 0.68
- NCMI 0.17
- MACD
- SNY 0.14
- NCMI -0.04
- Stochastic Oscillator
- SNY 30.56
- NCMI 18.42
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About NCMI National CineMedia Inc.
National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.